BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ravingerová T, Kindernay L, Barteková M, Ferko M, Adameová A, Zohdi V, Bernátová I, Ferenczyová K, Lazou A. The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection. Int J Mol Sci 2020;21:E7889. [PMID: 33114290 DOI: 10.3390/ijms21217889] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Zeng Y, Cao G, Lin L, Zhang Y, Luo X, Ma X, Aiyisake A, Cheng Q. Resveratrol Attenuates Sepsis-Induced Cardiomyopathy in Rats through Anti-Ferroptosis via the Sirt1/Nrf2 Pathway. J Invest Surg 2023;36:2157521. [PMID: 36576230 DOI: 10.1080/08941939.2022.2157521] [Reference Citation Analysis]
2 El Hajj S, Canabady-rochelle L, Gaucher C. Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases? Molecules 2023;28:2636. [DOI: 10.3390/molecules28062636] [Reference Citation Analysis]
3 Fratta Pasini AM, Stranieri C, Busti F, Di Leo EG, Girelli D, Cominacini L. New Insights into the Role of Ferroptosis in Cardiovascular Diseases. Cells 2023;12:867. [DOI: 10.3390/cells12060867] [Reference Citation Analysis]
4 Ju H, Liu T, Yang M, Cheng M, Wu G. Iron and atrial fibrillation: A review. Pacing Clin Electrophysiol 2023. [PMID: 36799332 DOI: 10.1111/pace.14678] [Reference Citation Analysis]
5 Massaiu I, Campodonico J, Mapelli M, Salvioni E, Valerio V, Moschetta D, Myasoedova VA, Cappellini MD, Pompilio G, Poggio P, Agostoni P. Dysregulation of Iron Metabolism-Linked Genes at Myocardial Tissue and Cell Levels in Dilated Cardiomyopathy. Int J Mol Sci 2023;24. [PMID: 36769209 DOI: 10.3390/ijms24032887] [Reference Citation Analysis]
6 Han X, Zhang J, Liu J, Wang H, Du F, Zeng X, Guo C. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries. Apoptosis 2023;28:108-23. [PMID: 36474078 DOI: 10.1007/s10495-022-01785-2] [Reference Citation Analysis]
7 Choy M, Zhen Z, Dong B, Chen C, Dong Y, Liu C, Liang W, Xue R. Mean corpuscular haemoglobin concentration and outcomes in heart failure with preserved ejection fraction. ESC Heart Fail 2023. [PMID: 36695165 DOI: 10.1002/ehf2.14225] [Reference Citation Analysis]
8 Chen Y, Li X, Wang S, Miao R, Zhong J. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases. Nutrients 2023;15. [PMID: 36771298 DOI: 10.3390/nu15030591] [Reference Citation Analysis]
9 Pan W, Jie W, Huang H. Vascular calcification: Molecular mechanisms and therapeutic interventions. MedComm (2020) 2023;4:e200. [PMID: 36620697 DOI: 10.1002/mco2.200] [Reference Citation Analysis]
10 Ni L, Cao J, Yuan C, Zhou LT, Wu X. Expression of Ferroptosis-Related Genes is Correlated with Immune Microenvironment in Diabetic Kidney Disease. Diabetes Metab Syndr Obes 2022;15:4049-64. [PMID: 36597492 DOI: 10.2147/DMSO.S388724] [Reference Citation Analysis]
11 Li H, Lin L, Xia YL, Xie Y, Yang X. Research progress on the role of ferroptosis in cardiovascular disease. Front Cardiovasc Med 2022;9:1077332. [PMID: 36620630 DOI: 10.3389/fcvm.2022.1077332] [Reference Citation Analysis]
12 Zhou F, Zhang Z, Wang M, Zhu W, Ruan J, Long H, Zhang Y, Gu N. Guanxin V attenuates myocardial ischaemia reperfusion injury through regulating iron homeostasis. Pharm Biol 2022;60:1884-98. [PMID: 36215067 DOI: 10.1080/13880209.2022.2123934] [Reference Citation Analysis]
13 Wei Z, Xie Y, Wei M, Zhao H, Ren K, Feng Q, Xu Y. New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1020918] [Reference Citation Analysis]
14 Jiang YH, Wu SY, Wang Z, Zhang L, Zhang J, Li Y, Liu C, Wu WZ, Xue YT. Bioinformatics analysis identifies ferroptosis‑related genes in the regulatory mechanism of myocardial infarction. Exp Ther Med 2022;24:748. [PMID: 36561967 DOI: 10.3892/etm.2022.11684] [Reference Citation Analysis]
15 Teng T, Kong C, Huang R, Ma Z, Hu C, Zhang X, Hu M, Tang Q. Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1046377] [Reference Citation Analysis]
16 Khastieva DR, Khasanov NR. Iron deficiency in patients with coronary artery disease. Russ J Cardiol 2022;27:4962. [DOI: 10.15829/1560-4071-2022-4962] [Reference Citation Analysis]
17 Guo S, Mao X, Li X, Ouyang H. Association between iron status and incident coronary artery disease: a population based-cohort study. Sci Rep 2022;12:17490. [PMID: 36261681 DOI: 10.1038/s41598-022-22275-0] [Reference Citation Analysis]
18 Zhang L, Dai X, Wang L, Cai J, Shen J, Shen Y, Li X, Zhao Y. Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease. Front Nutr 2022;9:961892. [PMID: 36304234 DOI: 10.3389/fnut.2022.961892] [Reference Citation Analysis]
19 Shen Y, Shen X, Wang S, Zhang Y, Wang Y, Ding Y, Shen J, Zhao J, Qin H, Xu Y, Zhou Q, Wang X, Shen J. Protective effects of Salvianolic acid B on rat ferroptosis in myocardial infarction through upregulating the Nrf2 signaling pathway. Int Immunopharmacol 2022;112:109257. [PMID: 36174419 DOI: 10.1016/j.intimp.2022.109257] [Reference Citation Analysis]
20 Zhang L, Liu J, Dai Z, Wang J, Wu M, Su R, Zhang D. Crosstalk between regulated necrosis and micronutrition, bridged by reactive oxygen species. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1003340] [Reference Citation Analysis]
21 Wang K, Chen XZ, Wang YH, Cheng XL, Zhao Y, Zhou LY, Wang K. Emerging roles of ferroptosis in cardiovascular diseases. Cell Death Discov 2022;8:394. [PMID: 36127318 DOI: 10.1038/s41420-022-01183-2] [Reference Citation Analysis]
22 Yan F, Li K, Xing W, Dong M, Yi M, Zhang H, Li T. Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/5124553] [Reference Citation Analysis]
23 Xie L, Fefelova N, Pamarthi SH, Gwathmey JK. Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease. Cells 2022;11:2726. [DOI: 10.3390/cells11172726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jung C, Rezar R, Wischmann P, Masyuk M, Datz C, Bruno RR, Kelm M, Wernly B. The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses. Int J Cardiol 2022:S0167-5273(22)01262-1. [PMID: 36055474 DOI: 10.1016/j.ijcard.2022.08.052] [Reference Citation Analysis]
25 Zhang L, Li W, Shi B, Zhang X, Gong K. Expression profiles and functions of ferroptosis-related genes in intimal hyperplasia induced by carotid artery ligation in mice. Front Genet 2022;13:964458. [DOI: 10.3389/fgene.2022.964458] [Reference Citation Analysis]
26 Lu P, Feng X, Li R, Deng P, Li S, Xiao J, Fang J, Wang X, Liu C, Zhu Q, Wang J, Fang Z, Gao L, Guo S, Jiang X, Zhu X, Qin T, Wei X, Yi X, Jiang D, Niu X. A Novel Serum Biomarker Model to Discriminate Aortic Dissection from Coronary Artery Disease. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/9716424] [Reference Citation Analysis]
27 Shen Y, Wang X, Shen X, Wang Y, Wang S, Zhang Y, Yao X, Xu Y, Sang M, Pan J, Qin Y, Zhou Q, Shen J. Geniposide Possesses the Protective Effect on Myocardial Injury by Inhibiting Oxidative Stress and Ferroptosis via Activation of the Grsf1/GPx4 Axis. Front Pharmacol 2022;13:879870. [DOI: 10.3389/fphar.2022.879870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sangeetha T, Ibrahim KS, Deepa S, Balamuralikrishnan B, Arun M, Velayuthaprabhu S, Saradhadevi KM, Anand AV. Efficiency of Coriandrum sativum (Linn.) and Petroselinum crispum (Mill.) in Enhancing Iron Absorption: An In Silico and In Vitro Approach. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-8. [DOI: 10.1155/2022/7359081] [Reference Citation Analysis]
29 Jarabicová I, Horváth C, Veľasová E, Bies Piváčková L, Vetešková J, Klimas J, Křenek P, Adameová A. Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension. J Cell Mol Med 2022. [PMID: 35393789 DOI: 10.1111/jcmm.17272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang S, Rao S, Yang M, Ma C, Hong F, Yang S. Role of Mitochondrial Pathways in Cell Apoptosis during He-Patic Ischemia/Reperfusion Injury. Int J Mol Sci 2022;23:2357. [PMID: 35216473 DOI: 10.3390/ijms23042357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Kumfu S, Chattipakorn SC, Chattipakorn N. Iron overload cardiomyopathy: Using the latest evidence to inform future applications. Exp Biol Med (Maywood) 2022;:15353702221076397. [PMID: 35130741 DOI: 10.1177/15353702221076397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Timoshnikov VA, Selyutina OY, Polyakov NE, Didichenko V, Kontoghiorghes GJ. Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine. Int J Mol Sci 2022;23:1247. [PMID: 35163169 DOI: 10.3390/ijms23031247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Sun X, Sun P, Zhen D, Xu X, Yang L, Fu D, Wei C, Niu X, Tian J, Li H. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.115902] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
34 张 敏. Study on Iron Metabolism in Cardiovascular Diseases. ACM 2022;12:2417-2423. [DOI: 10.12677/acm.2022.123349] [Reference Citation Analysis]
35 Li S, Zhang X. Iron in Cardiovascular Disease: Challenges and Potentials. Front Cardiovasc Med 2021;8:707138. [PMID: 34917655 DOI: 10.3389/fcvm.2021.707138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Li Y, Zheng N, Ding X. Mitophagy Disequilibrium, a Prominent Pathological Mechanism in Metabolic Heart Diseases. Diabetes Metab Syndr Obes 2021;14:4631-40. [PMID: 34858041 DOI: 10.2147/DMSO.S336882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Luo MY, Su JH, Gong SX, Liang N, Huang WQ, Chen W, Wang AP, Tian Y. Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases. Front Cell Dev Biol 2021;9:733908. [PMID: 34858973 DOI: 10.3389/fcell.2021.733908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
38 Xiao Z, Kong B, Fang J, Qin T, Dai C, Shuai W, Huang H. Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered 2021;12:9367-76. [PMID: 34787054 DOI: 10.1080/21655979.2021.2001913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
39 Zhang Y, Xin L, Xiang M, Shang C, Wang Y, Wang Y, Cui X, Lu Y. The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomed Pharmacother 2021;145:112423. [PMID: 34800783 DOI: 10.1016/j.biopha.2021.112423] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
40 Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H, Xu D. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 2021;12:10924-34. [PMID: 34699317 DOI: 10.1080/21655979.2021.1995994] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
41 Baier MJ, Wagner S, Hupf J, Evert K, Evert M, Sossalla S, Jungbauer C, Maier LS, Neef S, Mustroph J. Cardiac iron overload promotes cardiac injury in patients with severe COVID-19. Infection 2021. [PMID: 34669163 DOI: 10.1007/s15010-021-01722-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
42 Huang F, Yang R, Xiao Z, Xie Y, Lin X, Zhu P, Zhou P, Lu J, Zheng S. Targeting Ferroptosis to Treat Cardiovascular Diseases: A New Continent to Be Explored. Front Cell Dev Biol 2021;9:737971. [PMID: 34527678 DOI: 10.3389/fcell.2021.737971] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
43 Wang WJ, Jiang X, Gao CC, Chen ZW. Salusin‑β participates in high glucose‑induced HK‑2 cell ferroptosis in a Nrf‑2‑dependent manner. Mol Med Rep 2021;24:674. [PMID: 34296310 DOI: 10.3892/mmr.2021.12313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
44 Ponikowski P, Jankowska EA. Targeting Iron Deficiency in Heart Failure: Existing Evidence and Future Expectations. Circ Heart Fail 2021;14:e008299. [PMID: 34003689 DOI: 10.1161/CIRCHEARTFAILURE.121.008299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zhou Y, Zhou H, Hua L, Hou C, Jia Q, Chen J, Zhang S, Wang Y, He S, Jia E. Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis. Free Radic Biol Med 2021;171:55-68. [PMID: 33974977 DOI: 10.1016/j.freeradbiomed.2021.05.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 15.0] [Reference Citation Analysis]
46 Lillo-Moya J, Rojas-Solé C, Muñoz-Salamanca D, Panieri E, Saso L, Rodrigo R. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury. Antioxidants (Basel) 2021;10:667. [PMID: 33922912 DOI: 10.3390/antiox10050667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
47 Kobak KA, Franczuk P, Schubert J, Dzięgała M, Kasztura M, Tkaczyszyn M, Drozd M, Kosiorek A, Kiczak L, Bania J, Ponikowski P, Jankowska EA. Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression. Cells 2021;10:818. [PMID: 33917391 DOI: 10.3390/cells10040818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhai Z, Zou P, Liu F, Xia Z, Li J. Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy. Front Cell Dev Biol 2021;9:649045. [PMID: 33869204 DOI: 10.3389/fcell.2021.649045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
49 Bernatova I, Liskova S. Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies. Antioxidants (Basel) 2021;10:467. [PMID: 33809620 DOI: 10.3390/antiox10030467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
50 Pasqua T, Rocca C, Giglio A, Angelone T. Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications. J Clin Med 2021;10:721. [PMID: 33673114 DOI: 10.3390/jcm10040721] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
51 Chen X, Li X, Xu X, Li L, Liang N, Zhang L, Lv J, Wu YC, Yin H. Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation. Free Radic Res 2021;:1-11. [PMID: 33455488 DOI: 10.1080/10715762.2021.1876856] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]